MDXXF (Pharmala Biotech Holdings) Preferred Dividends: $0.00 Mil (TTM As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDXXF Pharmala Biotech Holdings Inc MDXXF
33 GF Score
Price $0.19
GF Value $0.17
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Pharmala Biotech Holdings Preferred Dividends?

Pharmala Biotech Holdings MDXXF -0.52% 33 Preferred Dividends is $0.00 Mil as of May. 2026. GuruFocus rates MDXXF with a GF Score™ of 33/100 and a GF Value™ of $0.17 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Pharmala Biotech Holdings's preferred dividends for the three months ended in May. 2026 was $0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in May. 2026 was $0.00 Mil.

Pharmala Biotech Holdings  (OTCPK:MDXXF) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Pharmala Biotech Holdings's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings Preferred Dividends Chart

Pharmala Biotech Holdings Annual Data
Trend Aug21 Aug22 Aug23 Aug24 Aug25
Preferred Dividends
0.00 0.00 0.00 0.00 0.00

Pharmala Biotech Holdings Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MDXXF
33GF Score
Pharmala Biotech Holdings Inc MDXXF
Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmala Biotech Holdings Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →
What does a Preferred Dividends of $0.00 Mil mean?
Pharmala Biotech Holdings (MDXXF) has a Preferred Dividends of $0.00 Mil as of May. 2026. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Pharmala Biotech Holdings and its competitors.
Is Pharmala Biotech Holdings' Preferred Dividends too high?
Pharmala Biotech Holdings' current Preferred Dividends is $0.00 Mil. Overall, Pharmala Biotech Holdings has a GF Score™ of 33/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmala Biotech Holdings' Preferred Dividends compare to VRTX and REGN?
Pharmala Biotech Holdings' Preferred Dividends of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Dividends for a Biotechnology company?
A good Preferred Dividends depends on the Biotechnology industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Dividends mean?
A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Pharmala Biotech Holdings and its competitors. Pharmala Biotech Holdings's current Preferred Dividends is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmala Biotech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Pharmala Biotech Holdings (MDXXF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.17, compared to a current price of $0.19 — trading 11.8% above its estimated fair value. The current Preferred Dividends is $0.00 Mil. Pharmala Biotech Holdings' overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Dividends calculated?
Preferred Dividends is calculated from a company's financial statements. For Pharmala Biotech Holdings (MDXXF), the current Preferred Dividends is $0.00 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmala Biotech Holdings (MDXXF) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmala Biotech Holdings stock appears to be overvalued. The current stock price of $0.19 is trading 11.8% above its estimated GF Value™ of $0.17. GuruFocus considers Pharmala Biotech Holdings to be Modestly Overvalued.

Key valuation signals for MDXXF:

  • Preferred Dividends: $0.00 Mil
  • GF Value™: $0.17 vs. price of $0.19 (11.8% above fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the MDXXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmala Biotech Holdings Business Description

Other Exchanges MDMA:Canada
Address 1 Adelaide Street East, Suite 801, Toranto, ON, CAN, M5C 2V9
Pharmala Biotech Holdings Inc is a Canadian Biotechnology company focused on the development, manufacture and sales of MDMA and MDXX class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The company produces its MDMA active pharmaceutical ingredient under the LaNeo brand through Good Manufacturing Practice (GMP) processes, aiming to address shortages for clinical trials investigating treatments for various disorders. It generates revenue from the sale of tablets, raw MDMA and MDXX compounds/formulations, and royalties from licensing of its IP.
33GF Score

Get the complete analysis for MDXXF

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.19
Price
$0.17
GF Value